Chad Bolema's life changed the day he learned he had Multiple Sclerosis (MS). Bolema, who was 26 years old at the time, ...
New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 Upon FDA approval, commercial launch activities to commence immediately with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback